Hari Pujar

No open positions remaining

Consumer Services

Health Technology

Profile

Hari Pujar is the founder of Mirai Bio, founded in 2021, serving as Director since 2024.
The current job is Chief Operating Officer at Tessera Therapeutics, Inc. since 2021.
Former job includes Chief Technology Officer at Spark Therapeutics, Inc. Education includes an MBA from the University of Pennsylvania, a doctorate from the University of Delaware, and an undergraduate degree from the Institute of Chemical Technology.

Hari Pujar active positions

Companies	Position	Start
Tessera Therapeutics, Inc. Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases	Chief Operating Officer	07/04/2021

All active positions of Hari Pujar

Former positions of Hari Pujar

Companies	Position	End
SPARK THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	-

See the detail of Hari Pujar's experience

Training of Hari Pujar

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hari Pujar's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Delaware University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Institute of Chemical Technology Institute of Chemical Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Spark Therapeutics, Inc. Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases	Health Technology
Tessera Therapeutics, Inc. Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases	Health Technology

See company connections